Company Filing History:
Years Active: 2002
Title: Andries Erik Braat: Innovator in Cell Death Mechanisms
Introduction
Andries Erik Braat is an inventive mind based in The Hague, Netherlands. He has made significant contributions to the field of biotechnology, particularly in understanding cell death mechanisms through his innovative work with Fas ligands.
Latest Patents
Andries Erik Braat holds a patent for a groundbreaking invention titled "Noncleavable Fas Ligand." This patent encompasses polypeptides that comprise a noncleavable form of a Fas ligand, which is instrumental in activating a Fas receptor-mediated pathway involved in cell death. The invention also includes pharmaceutical compositions featuring these polypeptides, along with nucleic acids encoding them and cell lines capable of expressing these nucleic acids. Furthermore, it outlines therapeutic and prophylactic methods for treating disorders arising from dysregulation or inappropriate stimulation of the Fas receptor-mediated pathway.
Career Highlights
Currently, Andries Erik Braat is associated with the University of California, where he continues to advance his research and innovations in the realm of molecular biology and therapeutic applications. His work focuses on harnessing the dynamics of the Fas receptor to develop effective treatments for various disorders.
Collaborations
Throughout his career, Andries has collaborated with notable colleagues such as Sang-Mo Kang and Steinunn Baekkeskov. These partnerships highlight the collaborative nature of scientific research, allowing for the exchange of ideas and expertise that drive innovation forward.
Conclusion
Andries Erik Braat's contributions through his patent on noncleavable Fas ligands signify a vital step in biopharmaceutical development. His work not only enhances the understanding of cell death mechanisms but also provides innovative therapeutic options for individuals suffering from related disorders. As he continues his journey at the University of California, the impact of his research is likely to resonate within the scientific community and beyond.